Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2005-10-18
2005-10-18
Wilder, Cynthia (Department: 1635)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S091200, C536S023100, C536S024300, C536S024310, C536S024330
Reexamination Certificate
active
06955875
ABSTRACT:
The invention features a method of diagnosing an iron disorder, e.g., hemochromatosis, or a genetic susceptibility to developing such a disorder in a mammal by determining the presence of a mutation in exon 2 or in an intron of an HFE nucleic acid.
REFERENCES:
patent: 4946778 (1990-08-01), Ladner et al.
patent: 5705343 (1998-01-01), Drayna et al.
patent: 5712098 (1998-01-01), Tsuchihashi et al.
patent: 5753438 (1998-05-01), Drayna et al.
patent: 5877015 (1999-03-01), Hardy et al.
patent: 5879892 (1999-03-01), Van Baren et al.
patent: 5879904 (1999-03-01), Brechot et al.
patent: 5879908 (1999-03-01), Laping et al.
patent: 6025130 (2000-02-01), Thomas et al.
patent: 6140305 (2000-10-01), Thomas et al.
patent: 6228594 (2001-05-01), Thomas et al.
patent: 6284732 (2001-09-01), Feder et al.
patent: 6355425 (2002-03-01), Rothenberg et al.
patent: WO 98/14466 (1998-04-01), None
Barton, et al., Two Novel Missence Mutations of the HFE Gene (I105T and G93R) and Identification of the S65C Mutation in Alabama Hemochromatosis Probands, Blood Cells, Molecules, and Diseases, vol. 25, No. 9, 1999. pp. 147-155.
Bernard et al., Homogenous Multiplex Genotyping of Hemochromatosis Mutations with Fluorescent Hybridization Probes, Am. J. Pathology, vol. 153, No. 4, Oct., 1998. pp. 1055-1061.
Cheng et al., Preparation and hybridization analysis of DNA/RNA fromE. colion micro fabricated bioelectric chips, Nature biotechnology, vol. 16, pp. 541-546, Jun. 1998.
Edman et al., Electric field directed nucleic acid hybridization on microchips, Nucleic Acids Research, 1997, vol. 25, No. 24, pp. 4907-4914.
Feder et al., “the Hemochromatosis Founder Mutation in HLA-H Disrupts . . . ”, Journal of Biological chemistry vol. 272, No. 22, pp. 14025-14028, 1997.
Mura et al., HFE Mutations Analysis in 711 Hemochromatosis Probands: Evidence for S65C Implication in Mild Form of Hemochromatosis; BLOOD, vol. 93, No. 8, 19999, pp. 2502-2505.
Nikiforov et al., Genetic Bit Analysis : a solid phase method for typing single nucleotide polymorphisms Nucleic Acids Research, 1994, vol. 22, No. 2, 4167-4175.
Sanchez et al., Prevalence of the Cys282Tyr and His63Asp HFE gene mutations in Spanish patients with hereditary hemochromatosis and in controls; Journal of Hepatology 1998; pp. 725-728.
Sosnowski et al., Rapids determination of single base mismatch mutations in DNA hybrids by direct electric field control, Proc. Natl. Acad. Sci. USA, vol. 94, pp. 1119-1123, Feb. 1997.
Wenz et al., A rapid automated SSCP multiplex capillary electrophoreses protocol that detects the two common mutations implicated in hereditary hemochromastosis (HH); Hum. Genet., vol. 104, No. 1, 1999, pp. 29-35.
Beutler et al., “HLA-H and Associated Proteins in Patients with Hemochromatosis” Mol. Med., vol. 3, No. 6, pp. 397-402, Jun. 1997.
Bjorkman et al., “The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens”, Nature vol. 329, Oct. 8, 1987.
Anges et al., “Strongly increased efficiency of altered peptide ligands by mannosylation” International Immunology, vol. 10, No. 9, pp. 1299-1304.
Bonkovsky et al., “Porphyria Cutanea Tarda, Hepatitis C, and HFE Gene Mutation sin North America”, Hepatology Jun. 1998; vol. 27, No. 6, pp. 1661-1669.
Bulaj et al., Clinical and Biochemical Abnormalities in People Heterozygous for Hemochromatosis, N.E. Journal of Medicine, Dec. 1996, Vo.. 335, No. 24, pp. 1799-1805.
Clevers et al., “Mutations of the hereditary hemochromatosis candidate gene HLA-H in porphyris cutanea tarda” N. Engl. Med May 1, 1997; 336(18):1327:8.
Douabin et al., “Ploymorphisms in the HFDE Gene” Hum. Hered. vol. 49, No. 1, pp. 21-26, Jan. 1999.
Fargion et al., “Genetic hemochromatosis in Italian patients with porphyria cutanea tarda”, Journal of Hepatology 1996; 24:564-569.
Gerhard, Walter, “Fusion of Cells in Suspension and Outgrowth of Hybrids in Conditioned Medium”, Plenum Press, Fusion Protocols, pp. 370-371, 1980.
Ghose et al., “Strategy for Linkage of Cytotoxic Agents”, Methods in Ezzymology, vol. 93, 1983, pp. 281-333.
Kohler et al., “Continuous cultures of fusted cells secreting antibody of predefined specificity”, Nature vol. 256, Aug. 7, 1975 pp. 495-497.
Lebron et al., “Crystal Structure of the Hemochromatosis Protein HFE and Characterization of Its Interaction with Transferring Receptor”, vol. 93, 111-123, Apr. 3, 1998.
Lefkowitch, MD, “Iron-Rich Foci in Chronic Viral Hepatitis”, Human Pathology, vol. 29, No. 2, Feb. 1998 pp., 116-118.
Mendez et al., “Familial porphyria Cutanea Tarda: Characterization of Seven Novel Uroporphyrinogen . . . ”, Am. J. Hum. Genet. 63:1363-1375, 1998.
Nickerson et al., “Automated DNA diagnostic using an ELISA-based oligonucleotide ligation assay”, Proc. Natl. Acad. Sci. USA, vol. 87, pp. 8923-8927, 1990.
O'Reilly et al., “Screening of Patients with Iron Overload to Identify Hemochromatosis and Porphyria utania Tarda”, Arch Dermatol/vol. 133, Sep. 1997, pp. 1098-1101.
Roberts et al., “Increased frequency of the haemochromatosis Cys282Tur mutation in sporadic prophyria cutanea tarda”, The Lancet 1997; 349:321-23.
Roberts et al., “The Frequency of Hemochromatosis-Associated Alleles is Increased in British Patients with Sporadic Porphyria Cutanea Tarda”, Hepatology vol. 25, No. 1, 1997, pp. 159-161.
Rust et al., “Mutagenically separated PCR (MS-PCR): a highly specific one step procedure for easy mutation detection”, Nucleic Acids Research, 1993, vol. 21, No. 6, 3623-3629.
Sampietro et al., “High Prevalence of the His63Asp HPE Mutation in Italian Patients with Porphyria Cutanea Tarda”, Hepatology vol. 27, No. 1, 1998.
Stuart et al., “The C282Y mutation in the haemochromatosis gene (HFE) and hepatitis C virus infection are independent cofactors for porphyria . . . ”,. Jour. Of Hepatology, 1998; 28: 404-409.
Worwood, Mark, “Revisiting various iron overload syndromes after the haemochromatosis gene discovery”, Journal of Hepatology, 1998; 28: 26-27.
Barton James C.
Rothenberg Barry E.
Sawada-Hirai Ritsuko
Beattle Ingrid A.
Billups-Rothenberg, Inc.
Mintz Levin Cohn Ferris Glovsky & Popeo PC
Susan Janine M.
Wilder Cynthia
LandOfFree
Mutations associated with iron disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mutations associated with iron disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mutations associated with iron disorders will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3471766